ReviewDiabetes, obesity & metabolism2022

Preventing all-cause hospitalizations in type 2 diabetes with sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A narrative review and proposed clinical approach.

Meir Schechter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.